Cited by 162Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesChronic Obstructive Pulmonary Disease (COPD) Research

Past major depression and smoking cessation outcome: A systematic review and meta-analysis update

Open access
Hitsman, Brian, Papandonatos, George D., McChargue, Dennis E., DeMott, Andrew, Herrera, María José, Spring, Bonnie, Borrelli, Belinda, Niaura, Raymond·2013·Addiction

Abstract

Aims: To update our prior meta‐analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome. Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000–2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face‐to‐face versus self‐help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study‐specific ORs for the effect of past MD on short‐term (≤3 months) and long‐term (≥6 months) abstinence were estimated and combined using random effects. Two‐way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD‐abstinence association. Results: MD+ smokers had 17% lower odds of short‐term abstinence (n = 35, OR = 0.83, 95% CI = 0.72–0.95, P = 0.009) and 19% lower odds of long‐term abstinence (n = 38, OR = 0.81, 95% CI = 0.67–0.97, P = 0.023) than MD‐ smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors. Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/add.12009

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [45]Diggle PJ Liang KY Zeger SL Analysis of longitudinal data 1994 New York, NY Oxford University Press

Cited by

Sorted by citations

Authors
Hitsman, B., Papandonatos, G. D., McChargue, D. E., DeMott, A., Herrera, M. J., Spring, B., Borrelli, B., & Niaura, R.
Affiliations
  • Northwestern University (US)
  • Brown University (US)
  • University of Nebraska–Lincoln (US)
  • Truth Initiative (US)
Corresponding author
Hitsman, Brian
Venue
Addiction
Publisher
Wiley
Published
2013-01-17
Volume
108
Issue
2
Pages
294-306
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2124905812
Cited by
162
References
75
Citations by year
2026: 5 · 2025: 8 · 2024: 4 · 2023: 11 · 2022: 10 · 2021: 7 · 2020: 21 · 2019: 13 · 2018: 19 · 2017: 15 · 2016: 15 · 2015: 18 · 2014: 10 · 2013: 6
FWCI
1.17
Type
journal article
Language
en
Open access
Locations
  • Addiction (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • National Institutes of Health (UL1TR000150)
  • Warren Alpert Medical School, Brown University
  • National Institute on Drug Abuse (K08DA017145)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
major depressive disorder, smoking cessation, smoking abstinence, cognitive behavioral therapy, self-help treatment, varenicline, treatment moderators
MeSH terms
Smoking Prevention, Major Depressive Disorder, Humans, Smoking, Time Factors, Cognitive Behavioral Therapy, Smoking Cessation, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review